Drug intelligence / Profile preview

XiangLian cream

Development stage: Preclinical
Lead developer: Guangdong Provincial Hospital of Traditional Chinese Medicine
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Topical

Overview

XiangLian cream is a topical traditional Chinese medicine (TCM) herbal preparation developed by the Guangdong Provincial Hospital of Chinese Medicine. It is formulated as a mixture of Flos Caryophylli (clove) and Rhizoma Coptidis (coptis) extracts. The cream is primarily used for its broad-spectrum antifungal, anti-inflammatory, and antipruritic properties to treat superficial fungal infections of the skin, such as tinea pedis (athlete's foot), tinea cruris (jock itch), tinea corporis (ringworm), and vulvovaginal candidiasis.

Other names: Flos Caryophylli and Rhizoma Coptidis creamXianglian cream

Beyond the preview

Go deeper on XiangLian cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XiangLian cream.